−55JPY
−3.82 BJPY
121.00 MJPY
56.30 M
About HEALIOS KK
Sector
CEO
Hardy T. S. Kagimoto
Headquarters
Tokyo
Website
Employees (FY)
64
Founded
2011
ISIN
JP3835100003
FIGI
BBG008NVX8S4
Healios KK engages in the research, development, and sale of cellular and regenerative medicine. It develops therapies for ischemic stroke, acute respiratory distress syndrome, liver disease, and age-regulated macular degeneration. The company was founded by Tadahisa Kagimoto on February 24, 2011 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4593 is 145 JPY — it has increased by 0.69% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange HEALIOS KK stocks are traded under the ticker 4593.
HEALIOS KK is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
4593 stock is 4.26% volatile and has beta coefficient of 0.41. Check out the list of the most volatile stocks — is HEALIOS KK there?
One year price forecast for HEALIOS KK has a max estimate of 400 JPY and a min estimate of 140 JPY.
4593 earnings for the last quarter are −9.91 JPY whereas the estimation was −13.62 JPY which accounts for 27.24% surprise. Estimated earnings for the next quarter are −14.63 JPY. See more details about HEALIOS KK earnings.
HEALIOS KK revenue for the last quarter amounts to 6.00 M JPY despite the estimated figure of 0 JPY. In the next quarter revenue is expected to reach −114.00 M JPY.
Yes, you can track HEALIOS KK financials in yearly and quarterly reports right on TradingView.
4593 stock has fallen by 8.81% compared to the previous week, the month change is a 11.54% rise, over the last year HEALIOS KK has showed a 54.97% decrease.
4593 net income for the last quarter is −1.73 B JPY, while the quarter before that showed −701.00 M JPY of net income which accounts for −146.93% change. Track more HEALIOS KK financial stats to get the full picture.
Today HEALIOS KK has the market capitalization of 12.98 B, it has increased by 10.83% over the last week.
No, 4593 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4593 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEALIOS KK stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 64.00 employees. See our rating of the largest employees — is HEALIOS KK on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HEALIOS KK technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HEALIOS KK stock shows the sell signal. See more of HEALIOS KK technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on HEALIOS KK future price: according to them, 4593 price has a max estimate of 400.00 JPY and a min estimate of 140.00 JPY. Read a more detailed HEALIOS KK forecast: see what analysts think of HEALIOS KK and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HEALIOS KK EBITDA is −3.16 B JPY, and current EBITDA margin is −2.49 K%. See more stats in HEALIOS KK financial statements.